000 01445 a2200433 4500
005 20250511205523.0
264 0 _c19910305
008 199103s 0 0 eng d
022 _a0024-3205
024 7 _a10.1016/0024-3205(91)90552-m
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEkman, A
245 0 0 _aPituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
_h[electronic resource]
260 _bLife sciences
_c1991
300 _a321-31 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a4-Butyrolactone
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBrain
_xmetabolism
650 0 4 _aCell Membrane
_xmetabolism
650 0 4 _aCorpus Striatum
_xmetabolism
650 0 4 _aKinetics
650 0 4 _aLimbic System
_xmetabolism
650 0 4 _aMale
650 0 4 _aPituitary Gland
_xmetabolism
650 0 4 _aQuinolines
_xpharmacology
650 0 4 _aRaclopride
650 0 4 _aRadioligand Assay
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Dopamine
_xdrug effects
650 0 4 _aReceptors, Dopamine D2
650 0 4 _aSalicylamides
_xmetabolism
650 0 4 _aSpiperone
_xmetabolism
650 0 4 _aTritium
700 1 _aEriksson, E
773 0 _tLife sciences
_gvol. 48
_gno. 4
_gp. 321-31
856 4 0 _uhttps://doi.org/10.1016/0024-3205(91)90552-m
_zAvailable from publisher's website
999 _c1831161
_d1831161